β-catenin Found as Key Driver in Aggressive Childhood Bone Cancer
Researchers at the University of Alberta have identified 'Active Beta-Catenin' (ABC) as a primary driver of aggressive pediatric osteosarcoma. This discovery highlights a potential new target for treating bone cancer that spreads to other organs.
Why it matters
Understanding the molecular drivers of metastatic bone cancer is critical for developing more effective therapies for children with poor survival outcomes.
"To the best of our knowledge, this is the first report that shows that ABC, and not -catenin, directly drives transcriptional activity of the Wnt/ -catenin pathway to enhance OS aggressiveness and promote an invasive phenotype."
The article summarizes scientific research findings objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in